Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Merck
McKesson
Express Scripts
Baxter
Medtronic
Johnson and Johnson

Last Updated: December 14, 2019

DrugPatentWatch Database Preview

DERMATOP E EMOLLIENT Drug Profile

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

When do Dermatop E Emollient patents expire, and what generic alternatives are available?

Dermatop E Emollient is a drug marketed by Valeant Bermuda and is included in one NDA.

The generic ingredient in DERMATOP E EMOLLIENT is prednicarbate. There are four drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the prednicarbate profile page.

US ANDA Litigation and Generic Entry Outlook for Dermatop E Emollient

A generic version of DERMATOP E EMOLLIENT was launched as prednicarbate by FOUGERA PHARMS on December 14th, 2019.

Summary for DERMATOP E EMOLLIENT
Drug patent expirations by year for DERMATOP E EMOLLIENT
Synonyms for DERMATOP E EMOLLIENT
(11|A)-17-[(Ethoxycarbonyl)oxy]-11-hydroxy-21-(1-oxopropoxy)pregna-1,4-diene-3,20-dione
[2-[(8S,9S,10R,11S,13S,14S,17R)-17-ethoxycarbonyloxy-11-hydroxy-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxo-ethyl] propanoate
[2-[(8S,9S,10R,11S,13S,14S,17R)-17-ethoxycarbonyloxy-11-hydroxy-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxoethyl] propanoate
11beta,17,21-Trihydroxypregna-1,4-diene-3,20-dione 17-(ethyl carbonate) 21-propionate
73771-04-7
771P047
AB00514017
AB2000755
AC-3521
AC1O8Q04
AKOS025402043
AN-6763
API0009173
BC226387
BPBio1_001066
BRD-K46137903-001-03-3
BSPBio_000968
CAS-73771-04-7
CCG-221044
CHEBI:135791
CHEMBL1200386
D05601
DB01130
Dermatop
Dermatop (TN)
DSSTox_CID_25502
DSSTox_GSID_45502
DSSTox_RID_80919
DTXSID9045502
EINECS 277-590-3
GTPL7605
HMS1571A10
HMS2098A10
HMS2230O11
HMS3715A10
Hoe 777
Hoe-777
MLS002154121
NCGC00016926-01
NCGC00179357-01
Peitel
Prednicarbat
PREDNICARBATE
Prednicarbate (USP/INN)
Prednicarbate [USAN:USP:INN:BAN]
Prednicarbato
Prednicarbato [INN-Spanish]
Prednicarbatum
Prednicarbatum [INN-Latin]
Prednisolone 17-(Ethyl Carbonate) 21-Propionate
Prednitop
Pregna-1,4-diene-3,20-dione, 17-((ethoxycarbonyl)oxy)-11-hydroxy-21-(1-oxopropoxy)-, (11beta)-
Pregna-1,4-diene-3,20-dione,17-[(ethoxycarbonyl)oxy]-11-hydroxy-21-(1-oxopropoxy)-, (11b)-
Prestwick0_001044
Prestwick1_001044
Prestwick2_001044
Prestwick3_001044
Q-101379
Regenit
S 77 0777
S 77-0777
S 770777
S-77 0777
S-770777
SC-81331
SCHEMBL3941
SMR001233428
SPBio_002904
SR-01000841201
SR-01000841201-2
Tox21_110687
UNII-V901LV1K7D
V901LV1K7D
ZINC3938652

US Patents and Regulatory Information for DERMATOP E EMOLLIENT

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Valeant Bermuda DERMATOP E EMOLLIENT prednicarbate CREAM;TOPICAL 020279-001 Oct 29, 1993 AB RX Yes Yes   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Moodys
Dow
McKinsey
Express Scripts
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.